切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2020, Vol. 14 ›› Issue (06) : 439 -443. doi: 10.3877/cma.j.issn.1674-0785.2020.06.008

所属专题: 文献

临床研究

BNP/NT-proBNP在老年心力衰竭患者心功能评估中的应用价值
范春炜1, 陈璟2, 车春香1, 王巧铃1, 林衔亮1,()   
  1. 1. 350000 福建福州,中国人民解放军联勤保障部队第九〇〇医院干部一科
    2. 350000 福建福州,中国人民解放军联勤保障部队第九〇〇医院护理部
  • 收稿日期:2020-02-18 出版日期:2020-06-15
  • 通信作者: 林衔亮

Application value of BNP/NT-proBNP in evaluation of cardiac function in elderly patients with heart failure

Chunwei Fan1, Jing Chen2, Chunxiang Che1, Qiaoling Wang1, Xianliang Lin1,()   

  1. 1. Cadre Ward Section, 900th Hospital of Joint Logistics Support Force, Fuzhou 350000, China
    2. Nursing Department, 900th Hospital of Joint Logistics Support Force, Fuzhou 350000, China
  • Received:2020-02-18 Published:2020-06-15
  • Corresponding author: Xianliang Lin
  • About author:
    Corresponding author: Lin Xianliang, Email:
引用本文:

范春炜, 陈璟, 车春香, 王巧铃, 林衔亮. BNP/NT-proBNP在老年心力衰竭患者心功能评估中的应用价值[J/OL]. 中华临床医师杂志(电子版), 2020, 14(06): 439-443.

Chunwei Fan, Jing Chen, Chunxiang Che, Qiaoling Wang, Xianliang Lin. Application value of BNP/NT-proBNP in evaluation of cardiac function in elderly patients with heart failure[J/OL]. Chinese Journal of Clinicians(Electronic Edition), 2020, 14(06): 439-443.

目的

通过检测老年心力衰竭患者血清中的BNP/NT-proBNP,探讨其在心力衰竭中的诊断价值。

方法

2017年1月至2019年12月中国人民解放军联勤保障部队第九〇〇医院干部一科收治的169例老年慢性病患者,按照美国纽约心脏病协会(NYHA)心功能分级,将患者分为A组(无心力衰竭者)、B组(NYHA Ⅰ+Ⅱ级)和C组(NYHA Ⅲ+Ⅳ级),使用多普勒超声检测患者左心室射血分数(LVEF)。入院时测定患者6 min步行试验(6MWT),并检测患者血清BNP、NT-proBNP、C反应蛋白(CRP)、降钙素原、肌酐、尿素氮、球蛋白、白蛋白、胱抑素C,采用方差分析比较不同心功能分级的患者血清BNP/NT-proBNP是否具有差异性,采用Pearson相关分析法分析BNP/NT-proBNP与上述指标间的相关性。另外,在各组内按不同肾功能或是否合并感染分出亚组,进一步分析在心力衰竭合并肾功能不全或感染时BNP/NT-proBNP是否具有差异性。

结果

随着心功能的下降,3组BNP/NT-proBNP逐渐降低(0.252±0.065,0.221±0.062,0.195±0.071,F=9.807,P<0.001),该比值与LVEF、6MWT具有显著正相关性(r=0.300,P<0.001;r=0.230,P=0.003)。3组中,未合并感染者BNP/NT-proBN与合并感染患者差异均无统计学意义(P均>0.05)。在B组和C组内,GFR<30 ml/(min?1.73 m2)的患者BNP/NT-proBNP较GFR≥30 ml/(min?1.73 m2)的患者低[B组:(0.128±0.110)vs(0.225±0.056),C组:(0.135±0.046)vs(0.199±0.077)],差异具有统计学意义(B组:t=6.578,P<0.001,C组:t=2.819,P=0.007),而当排除GFR<30 ml/(min?1.73 m2)的患者进行进一步研究发现,在3组内,GFR<60 ml/(min?1.73 m2)的患者BNP/NT-proBNP与GFR≥60 ml/(min?1.73 m2)的患者比较,差异均无统计学意义(P均>0.05)。

结论

BNP/NT-proBNP在老年心力衰竭患者心功能诊断及判断预后中具有重要价值。

Objective

To investigate the diagnostic value of serum brain natriuretic peptide (BNP)/N terminal pro-BNP (NT-proBNP) in elderly patients with heart failure (HF).

Methods

A total of 169 elderly patients with chronic diseases admitted to our department from January 2017 to December 2019 were selected. According to New York Heart Association (NYHA) cardiac function classification, the patients were divided into Group A (No HF), Group B (NYHA Ⅰ+ Ⅱ), and Group C (NYHA Ⅲ+ Ⅳ). Left ventricular ejection fraction (LVEF) was detected by Doppler ultrasound. The 6-minute walking distance (6MWT), serum BNP, NT-proBNP, C-reactive protein (CRP), calcitonin, creatinine, urea nitrogen, globulin, albumin, and cystatin C were measured on admission. The differences of serum BNP/NT-proBNP were compared by ANOVA in patients with different cardiac function grades and the relationship between BNP/NT-proBNP and the above indexes was analyzed with Pearson′s correlation analysis. Each group was divided into sub-groups according to different renal functions or whether or not they were combined with infections, and the differences of BNP/NT-proBNP in HF combined with renal insufficiency or infection were further compared.

Results

With the decrease of cardiac function, BNP/NT-proBNP decreased gradually (0.252±0.065, 0.221±0.062, and 0.195±0.071, F=9.807, P<0.001), and the ratio was significantly correlated with LVEF and 6MWT (r=0.300, P<0.001; r=0.230, P=0.003). In the three groups, the BNP/NT-proBNP level did not differ significantly between the uninfected patients and those with combined infection P>0.05). In group B and C, patients with a glomerular filtration rate (GFR)<30 ml/(min?1.73 m2) had significantly lower BNP/NT-proBNP than those with a GFR≥30 ml/(min?1.73 m2) (Group B: 0.128±0.110 vs 0.255±0.056, t=6.578, P<0.001; Group C: 0.135±0.046 vs 0.199±0.077, t=2.819, P=0.007). However, when the patients with a GFR<30 ml/(min?1.73 m2) were excluded for further study, it was found that in the three groups, the differences of BNP/NT-proBNP in patients with a GFR<60 ml/(min?1.73 m2) were not statistically significant compared with those with a GFR≥60 ml/(min?1.73 m2) (P>0.05).

Conclusion

BNP/NT-proBNP plays an important role in the diagnosis and prognosis of HF in elderly patients.

表1 3组老年患者合并疾病的分布情况[例(%)]
表2 感染组与非感染组BNP/NT-proBNP的比较(±s
表3 以GFR=30 ml/(min?1.73 m2)为界的2组患者BNP/NT-proBNP的比较(±s
表4 以GFR=60 ml/(min?1.73 m2)为界的2组患者BNP/NT-proBNP的比较(±s
1
Maisel A, Mueller C, Adams K Jr, et al. State of the art: using natriuretic peptide levels in clinical practice [J]. Eur J Heart Fail, 2008, 10(9): 824-839.
2
Liang F, O′Rear J, Schellenberger U, et al. Evidence for functional heterogeneity of circulating B-type natriuretic peptide [J]. J Am Coll Cardiol, 2007, 49(10): 1071-1078.
3
Grimm G, Resl M, Heinisch BB, et al. B-type natriuretic peptide increases cortisol and catecholamine concentrations in healthy subjects [J]. J Appl Physiol (1985), 2017, 122(5): 1249-1254.
4
关振华,陈延军. 脑钠肽(BNP和NT-proBNP)在肥胖合并心力衰竭患者诊断及临床应用中的研究 [J]. 医学研究杂志, 2016, 45(10): 182-185.
5
Luchner A, Hengstenberg C, Löwel H, et al. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP [J]. Hypertension, 2005, 46(1): 118-123.
6
郑泳森. NT-BNP在心衰合并慢性肾功能不全诊断中的临床意义 [J]. 黑龙江医学, 2016, 40(1): 72-73.
7
秦卓,何威,高磊, 等. 脓毒血症患者血清BNP、ALT、AST、血流动力学水平与患者病情严重程度的相关性 [J]. 医学临床研究, 2019, 36(8): 1552-1553.
8
赵瑞敏,冯玫. 多病共存患者情况调查分析 [J]. 临床医药实践, 2016, 25(8): 604-606.
9
Bettencourt P, Azevedo A, Pimenta J, et al. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients [J]. Circulation, 2004, 110(15): 2168-2174.
10
Suzuki S, Sugiyama S. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors [J]. Intern Med, 2018, 57(18): 2621-2630.
[1] 农云洁, 黄小桂, 黄裕兰, 农恒荣. 超声在多重肺部感染诊断中的临床应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 872-876.
[2] 皮尔地瓦斯·麦麦提玉素甫, 李慧灵, 艾克拜尔·艾力, 李赞林, 王志, 克力木·阿不都热依木. 生物补片修补巨大复发性腹壁切口疝临床疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 624-628.
[3] 顾熙, 徐子宇, 周澍, 张吴楼, 张业鹏, 林昊, 刘宗航, 嵇振岭, 郑立锋. 腹股沟疝腹膜前间隙无张力修补术后补片感染10 例报道[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 665-669.
[4] 宋俊锋, 张珍珍. 单侧初发性腹股沟斜疝老年患者经腹腹膜前疝修补术中残余疝囊腹直肌下缘固定效果评估[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 670-674.
[5] 臧宇, 姚胜, 朱新勇, 戎世捧, 田智超. 低温等离子射频消融治疗腹壁疝术后补片感染的临床效果[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 687-692.
[6] 杨闯, 马雪. 腹壁疝术后感染的危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 693-696.
[7] 张晋伟, 董永红, 王家璇. 基于GBD2021 数据库对中国与全球老年人疝疾病负担和健康不平等的分析比较[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 708-716.
[8] 赵月, 田坤, 张宗明, 郭震天, 刘立民, 张翀, 刘卓. 降钙素原对老年急性重度胆囊炎发生的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 801-806.
[9] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[10] 陈意志. 核磁共振钆造影剂导致的肾源性系统性纤维化[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 358-358.
[11] 黄韬, 杨晓华, 薛天森, 肖睿. 改良“蛋壳”技术治疗老年OVCF及对脊柱矢状面平衡参数、预后的影响[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 340-348.
[12] 王贝贝, 崔振义, 王静, 王晗妍, 吕红芝, 李秀婷. 老年股骨粗隆间骨折患者术后贫血预测模型的构建与验证[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 355-362.
[13] 贾玲玲, 滕飞, 常键, 黄福, 刘剑萍. 心肺康复在各种疾病中应用的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 859-862.
[14] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
[15] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
阅读次数
全文


摘要